Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study-Reference-Cited by-同舟云学术

Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study

Published:2021-11-08 Issue:2 Volume:129 Page:258-268
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Wettstein Marian S.¹²³⁴^ORCID,Baxter Nancy N.²³,Sutradhar Rinku²³,Mamdani Muhammad²³,Song Pham³,Qadri Syed R.¹,Li Kathy¹,Liu Ning³,Kwast Theodorus⁵,Hermanns Thomas⁴,Kulkarni Girish S.¹²³

Affiliation:

1. Division of Urology Department of Surgery Princess Margaret Cancer Centre University Health Network University of Toronto Toronto ON Canada

2. Institute of Health Policy, Management and Evaluation University of Toronto Toronto ON Canada

3. ICES Toronto ON Canada

4. Department of Urology University Hospital of Zurich University of Zurich Zurich Switzerland

5. Department of Pathology Princess Margaret Cancer Centre University Health Network University of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15622

Reference30 articles.

1. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

3. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

4. National Comprehensive Cancer Network.Bladder cancer (Version 1.2020). Available at:https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed December 2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy;Japanese Journal of Clinical Oncology;2023-11-16

2. Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG‐treated disease;International Journal of Urology;2023-07-31

3. Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era;European Urology Focus;2023-07

4. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs;Frontiers in Oncology;2023-06-02

5. Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective;Frontiers in Oncology;2023-01-31